Author Index

Search or browse for an author across our entire electronic archive

Search results for: O
Results 191 - 200 of 688 shown below

  • Ogg, G S

    G S Ogg, P R Dunbar, V Cerundolo, A J McMichael, N R Lemoine and P Savage

    Sensitization of tumour cells to lysis by virus-specific CTL using antibody-targeted MHC class I/peptide complexes

    doi:10.1054/bjoc.1999.1042

  • Ogi, K

    N Tanaka, T Odajima, K Ogi, T Ikeda and M Satoh

    Expression of E-cadherin, alpha-catenin, and beta-catenin in the process of lymph node metastasis in oral squamous cell carcinoma

    doi:10.1038/sj.bjc.6601124

  • K Terasawa, M Toyota, S Sagae, K Ogi, H Suzuki, T Sonoda, K Akino, R Maruyama, N Nishikawa, K Imai, Y Shinomura, T Saito and T Tokino

    Epigenetic inactivation of TCF2 in ovarian cancer and various cancer cell lines

    advance online publication, 2006-02-14 00:00:00.000;

    doi:10.1038/sj.bjc.6602984

  • Ogimoto, I

    Y Kurozawa, I Ogimoto, A Shibata, T Nose, T Yoshimura, H Suzuki, R Sakata, Y Fujita, S Ichikawa, N Iwai and A Tamakoshi

    Coffee and risk of death from hepatocellular carcinoma in a large cohort study in Japan

    advance online publication, 2005-08-09 00:00:00.000;

    doi:10.1038/sj.bjc.6602737

  • Y Fujita, A Shibata, I Ogimoto, Y Kurozawa, T Nose, T Yoshimura, H Suzuki, N Iwai, R Sakata, S Ichikawa and A Tamakoshi

    The effect of interaction between hepatitis C virus and cigarette smoking on the risk of hepatocellular carcinoma

    advance online publication, 2006-02-07 00:00:00.000;

    doi:10.1038/sj.bjc.6602981

  • K Wakai, Y Kurozawa, A Shibata, Y Fujita, K Kotani, I Ogimoto, M Naito, K Nishio, H Suzuki, T Yoshimura and A Tamakoshi

    Liver cancer risk, coffee, and hepatitis C virus infection: a nested case–control study in Japan

    advance online publication, 2007-07-17 00:00:00.000;

    doi:10.1038/sj.bjc.6603891

  • Ogink, J

    J Meijer, J Ogink and E Roos

    Effect of the chemokine receptor CXCR7 on proliferation of carcinoma cells in vitro and in vivo

    advance online publication, 2008-10-14 00:00:00.000;

    doi:10.1038/sj.bjc.6604727

  • Ogino, S

    J Souglakos, J Philips, R Wang, S Marwah, M Silver, M Tzardi, J Silver, S Ogino, S Hooshmand, E Kwak, E Freed, J A Meyerhardt, Z Saridaki, V Georgoulias, D Finkelstein, C S Fuchs, M H Kulke and R A Shivdasani

    Prognostic and predictive value of common mutations for treatment response and survival in patients with metastatic colorectal cancer

    advance online publication, 2009-07-14 00:00:00.000;

    doi:10.1038/sj.bjc.6605164

  • Ogino, T

    H Mineta, K Miura, T Ogino, S Takebayashi, K Misawa, Y Ueda, I Suzuki, M Dictor, Å Borg and J Wennerberg

    Prognostic value of vascular endothelial growth factor (VEGF) in head and neck squamous cell carcinomas

    doi:10.1054/bjoc.2000.1357

  • Ogisawa, K

    Y Nobuhara, N Onoda, Y Yamashita, M Yamasaki, K Ogisawa, T Takashima, T Ishikawa and K Hirakawa

    Efficacy of epidermal growth factor receptor-targeted molecular therapy in anaplastic thyroid cancer cell lines

    advance online publication, 2005-03-22 00:00:00.000;

    doi:10.1038/sj.bjc.6602461

  • Ogita, M

    Y Park, K Okamura, S Mitsuyama, T Saito, J Koh, S Kyono, K Higaki, M Ogita, T Asaga, H Inaji, H Komichi, N Kohno, K Yamazaki, F Tanaka, T Ito, H Nishikawa, A Osaki, H Koyama and T Suzuki

    Uracil-tegafur and tamoxifen vs cyclophosphamide, methotrexate, fluorouracil, and tamoxifen in post-operative adjuvant therapy for stage I, II, or IIIA lymph node-positive breast cancer: a comparative study

    advance online publication, 2009-07-28 00:00:00.000;

    doi:10.1038/sj.bjc.6605218

  • Y Park, K Okamura, S Mitsuyama, T Saito, J Koh, S Kyono, K Higaki, M Ogita, T Asaga, H Inaji, H Komichi, N Kohno, K Yamazaki, F Tanaka, T Ito, H Nishikawa, A Osaki, H Koyama and T Suzuki

    Uracil-tegafur and tamoxifen versus cyclophosphamide, methotrexate, fluorouracil, and tamoxifen in postoperative adjuvant therapy for stage I, II, or IIIA lymph node-positive breast cancer: a comparative study

    doi:10.1038/sj.bjc.6605295

  • Ogiwara, A

    J Maeda, T Hirano, A Ogiwara, S Akimoto, T Kawakami, Y Fukui, T Oka, Y Gong, R Guo, H Inada, K Nawa, M Kojika, Y Suga, T Ohira, K Mukai and H Kato

    Proteomic analysis of stage I primary lung adenocarcinoma aimed at individualisation of postoperative therapy

    advance online publication, 2008-01-22 00:00:00.000;

    doi:10.1038/sj.bjc.6604197

  • J Maeda, T Hirano, A Ogiwara, S Akimoto, T Kawakami, Y Fukui, T Oka, Y Gong, R Guo, H Inada, K Nawa, M Kojika, Y Suga, T Ohira, K Mukai and H Kato

    Proteomic analysis of stage I primary lung adenocarcinoma aimed at individualization of postoperative therapy

    doi:10.1038/sj.bjc.6604414

  • Ogoshi, S

    M Matsumoto, M Furihata, T Ishikawa, Y Ohtsuki and S Ogoshi

    Comparison of deregulated expression of cyclin D1 and cyclin E with that of cyclin-dependent kinase 4 (CDK4) and CDK2 in human oesophageal squamous cell carcinoma

    doi:10.1038/sj.bjc.6690348